CARL
Carlsmed Inc (CARL)
Healthcare • NASDAQ • $9.80+0.51%
- Symbol
- CARL
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Health Information Services
- Price
- $9.80
- Daily Change
- +0.51%
- Market Cap
- $266.41M
- Trailing P/E
- N/A
- Forward P/E
- -6.83
- 52W High
- $17.19
- 52W Low
- $8.50
- Analyst Target
- $18.40
- Dividend Yield
- N/A
- Beta
- N/A
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Company websiteResearch CARL on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.